This is a news story, published by Global News, that relates primarily to Abbott Laboratories news.
For more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Global News, you can click here:
more news from Global NewsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
MPXV assay. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest mpox virus DNA news, laboratory testing capacity news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
clinical laboratory personnelGlobal News
•
84% Informative
The agency granted approval for emergency use of Abbott Laboratories unit’s PCR test, Alinity m MPXV assay.
The test enables detection of mpox virus DNA from human skin lesion swabs.
The agency said it was evaluating three new mpox diagnostic tests for its emergency use listing (EUL).
VR Score
93
Informative language
99
Neutral language
83
Article tone
formal
Language
English
Language complexity
80
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links